Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Seattle Children's Hospital at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Seattle Children's Hospital brings 4 presentations to ASH 2026 in New Orleans. Its program centres on pediatric leukemia and sickle cell care. Sessions cover how to treat ALL, chemo-immunotherapy in children and transfusion reactions in sickle cell disease.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
Pediatric hospital and research institute in Seattle, Washington.
Talk
Sat Dec 12
8:00am–9:00am
Talk
Sun Dec 13
4:30pm–5:45pm
Immune-Mediated Transfusion Reactions in Sickle Cell Disease: A Practical Approach
Telling apart hyperhemolysis and delayed hemolytic transfusion reactions in sickle cell disease, and why it matters for prognosis, future transfusions and treatment.
Red cells
Talk
Mon Dec 14
10:30am–11:45am
Next Steps for Treatment of Pediatric ALL in the Era of Frontline Chemo-Immunotherapy
Whether adding inotuzumab or CAR-T to frontline treatment of childhood B-cell acute lymphoblastic leukemia can safely reduce chemotherapy and its toxicity.
Leukemias
Session
Mon Dec 14
10:30am–11:45am
The Golden Era of ALL Management: Rapid Advances Across the Age Spectrum
How blinatumomab, CAR-T cells and other immunotherapies are reshaping acute lymphoblastic leukemia care and reducing chemotherapy across all ages.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Seattle Children's Hospital

Tell us what you sell and we’ll find the people at Seattle Children's Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction